WHO ICTRP trial
‘Colours’: Skin testing as a new technique of estimating the comparative risk of…
ACTRN12622001117707 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12622001117707 |
|---|---|
| Public title | ‘Colours’: Skin testing as a new technique of estimating the comparative risk of anaphylaxis to neuromuscular blocking agents by consideration of cross-reactivity. |
| Scientific title | ‘Colours’: Skin testing as a new technique of estimating the comparative risk of anaphylaxis to neuromuscular blocking agents in adults with known NMBA anaphylaxis by consideration of cross-reactivity. |
| Primary sponsor | Sir Charles Gairdner Hospital |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Anaphylaxis; Anaphylaxis;Anaesthesiology - Anaesthetics;Inflammatory and Immune System - Allergies |
| Interventions | Observational only. Patients will undergo skin testing regardless of participation in this trial. Patients will not have any change in involvement based on participation in this study. Their data that would normally be collected will just… |
| Registration date | Dec 8, 2022 |
| Target size | 200 |
| Secondary IDs | Nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: